Celanese to Hold First Quarter Earnings Conference Call on May 9, 2024
Celanese Corporation Declares Quarterly Dividend of $0.70 Per Share
Chemical Marketing & Economics Honors Celanese Chairman, CEO and President Lori J. Ryerkerk with STEM Leadership Award for Corporate Reinvention
Celanese Completes Series of Strategic Actions Across its Global Acetyl Chain
Celanese Achieves ISCC CFC Certification for Low Carbon CCU Methanol
Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies
Celanese Announces Commercial Launch of Glaukos' iDose® TR (Travoprost Intracameral Implant) Using Celanese's VitalDose® Ethylene Vinyl Acetate (EVA)
Timothy Go Elected to Celanese Board of Directors
Celanese Corporation Reports Full Year 2023 and Fourth Quarter Earnings
Celanese Low-Carbon ECO-CC Products Available Through U.S. Department of Energy Procurement Grant Program
